Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 148

1.

Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy.

Weinstock LB, Fern SE, Duntley SP.

Dig Dis Sci. 2008 May;53(5):1252-6. Epub 2007 Oct 13.

PMID:
17934858
2.

Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms.

Weinstock LB, Klutke CG, Lin HC.

Dig Dis Sci. 2008 May;53(5):1246-51. Epub 2007 Oct 12.

PMID:
17932763
3.

A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.

Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.

Neurogastroenterol Motil. 2014 Jun;26(6):794-802. doi: 10.1111/nmo.12331. Epub 2014 Mar 18.

4.

Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.

Weinstock LB, Walters AS.

Sleep Med. 2011 Jun;12(6):610-3. doi: 10.1016/j.sleep.2011.03.007. Epub 2011 May 13.

PMID:
21570907
5.

Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.

Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitraşcu DL.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):143-7.

PMID:
24620626
6.

Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.

Weinstock LB, Geng B, Brandes SB.

Can J Urol. 2011 Aug;18(4):5826-30.

PMID:
21854715
7.

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A.

World J Gastroenterol. 2009 Jun 7;15(21):2628-31.

8.

Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?

Stoicescu A, Andrei M, Becheanu G, Stoicescu M, Nicolaie T, Diculescu M.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):766-72.

PMID:
23272525
9.

Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.

Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.

Rom J Intern Med. 2014;52(3):143-50.

PMID:
25509557
10.

Prevalence of restless legs syndrome in patients with irritable bowel syndrome.

Basu PP, Shah NJ, Krishnaswamy N, Pacana T.

World J Gastroenterol. 2011 Oct 21;17(39):4404-7. doi: 10.3748/wjg.v17.i39.4404.

11.

Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.

Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20.

12.

Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.

Collins BS, Lin HC.

J Pediatr Gastroenterol Nutr. 2011 Apr;52(4):382-6. doi: 10.1097/MPG.0b013e3181effa3b.

PMID:
21240023
13.

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.

Boltin D, Perets TT, Shporn E, Aizic S, Levy S, Niv Y, Dickman R.

Ann Clin Microbiol Antimicrob. 2014 Oct 17;13:49. doi: 10.1186/s12941-014-0049-x.

15.

Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.

Bae S, Lee KJ, Kim YS, Kim KN.

J Korean Med Sci. 2015 Jun;30(6):757-62. doi: 10.3346/jkms.2015.30.6.757. Epub 2015 May 13.

16.

Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.

Lombardo L, Foti M, Ruggia O, Chiecchio A.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):504-8. doi: 10.1016/j.cgh.2009.12.022. Epub 2010 Jan 6.

PMID:
20060064
17.

Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.

Cuoco L, Salvagnini M.

Minerva Gastroenterol Dietol. 2006 Mar;52(1):89-95.

PMID:
16554709
18.

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M.

Gut. 2007 Jun;56(6):802-8. Epub 2006 Dec 5.

19.

Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.

Parodi A, Dulbecco P, Savarino E, Giannini EG, Bodini G, Corbo M, Isola L, De Conca S, Marabotto E, Savarino V.

J Clin Gastroenterol. 2009 Nov-Dec;43(10):962-6. doi: 10.1097/MCG.0b013e3181a099a5.

PMID:
19525858
20.

Rifaximin treatment for symptoms of irritable bowel syndrome.

Fumi AL, Trexler K.

Ann Pharmacother. 2008 Mar;42(3):408-12. doi: 10.1345/aph.1K345. Epub 2008 Feb 26. Review.

PMID:
18303148
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk